Avantor (AVTR)
NYSEHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$14.97-1.45%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · AVTR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenues | 6,561.1 | 6,552.2 | 6,783.6 | 6,967.2 | 7,512.4 | 7,386.1 | 6,393.6 | 6,040.3 |
| Total Revenues | 6,561.1 | 6,552.2 | 6,783.6 | 6,967.2 | 7,512.4 | 7,386.1 | 6,393.6 | 6,040.3 |
| Cost of Revenues | 4,473.0 | 4,412.8 | 4,504.3 | 4,603.4 | 4,909.6 | 4,883.4 | 4,313.1 | 4,119.6 |
| Gross Profit | 2,088.1 | 2,139.4 | 2,279.3 | 2,363.8 | 2,602.8 | 2,502.7 | 2,080.5 | 1,920.7 |
| Operating Expenses & Income | ||||||||
| Selling, General & Admin | 1,599.1 | 1,595.5 | 1,641.1 | 1,506.6 | 1,472.6 | 1,530.5 | 1,373.7 | 1,368.9 |
| Other Operating Expenses, Total | 1.4 | (20.7) | (1.2) | 5.8 | (0.8) | — | — | — |
| Operating Income | (301.1) | (246.2) | 1,084.8 | 696.4 | 1,130.2 | 972.2 | 706.8 | 551.8 |
| Earnings from Continuing Operations | ||||||||
| Interest Expense | — | 169.8 | 218.8 | 284.8 | 265.8 | 217.4 | 307.6 | 440.0 |
| Asset Writedown | — | 785.0 | — | 160.8 | 0.0 | 0.0 | — | — |
| EBT, Incl. Unusual Items | (472.0) | (441.3) | 853.9 | 410.5 | 851.1 | 753.0 | 62.3 | 40.6 |
| Income Tax Expense | 106.0 | 88.9 | 142.4 | 89.4 | 164.6 | 180.4 | (54.3) | 2.8 |
| Net Income | ||||||||
| Minority Interest | — | — | — | — | — | — | — | 0.0 |
| Net Income | (578.0) | (530.2) | 711.5 | 321.1 | 686.5 | 572.6 | 116.6 | 37.8 |
| Per Share | ||||||||
| Basic EPS | (0.85) | (0.78) | 1.05 | 0.48 | 1.02 | 0.86 | 0.09 | — |
| Diluted EPS | (0.85) | (0.78) | 1.04 | 0.47 | 1.01 | 0.85 | 0.09 | — |
| Revenue per Share | 9.69 | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 676.2 | 680.6 | 679.6 | 675.6 | 650.9 | 590.5 | 576.3 | — |
| Diluted Weighted Avg Shares | 677.2 | 680.6 | 681.9 | 678.4 | 679.4 | 599.6 | 583.4 | — |
| Supplemental | ||||||||
| EBITDA | — | 164.0 | 1,490.3 | 1,098.7 | 1,535.7 | 1,351.4 | 1,102.2 | 950.7 |
| EBIT | (301.1) | (246.2) | 1,084.8 | 696.4 | 1,130.2 | 972.2 | 706.8 | 551.8 |
| Effective Tax Rate | -22.5% | — | — | 21.8% | 19.3% | 24.0% | -87.2% | 6.9% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.